Comment by jibal
16 hours ago
Sorry, it does not apply ... this drug inhibits (for the first time) the KRAS mutation (previously considered "undruggable") that is the primary cause of 90% of pancreatic cancers and 50% of colon cancers.
16 hours ago
Sorry, it does not apply ... this drug inhibits (for the first time) the KRAS mutation (previously considered "undruggable") that is the primary cause of 90% of pancreatic cancers and 50% of colon cancers.
No reason to be sorry, that sounds like this is even better news then :)
I just meant that this doesn't apply to lymphoma, which is not caused by KRAS.